fragile x syndrome market

Fragile X Syndrome Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2019 - 2028

  • Published Date: 2022-12-26
  • Report ID: 138132
  • Pages: 200
  • Format: prudent report format

Report Overview

The global Fragile-X-Syndrome market size stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period

Fragile X syndrome is a genetic disorder that leads to various developmental hitches including learning disabilities and cognitive impairment. Men are more often affected by this disorder than women

In case of affected individuals, there is delayed development of speech and language by age 2. Majority of men suffering with fragile X syndrome suffer from mild to moderate intellectual disability compared to one-third women. Children suffering with fragile X syndrome could also show anxiety and hyperactive behavior such as fidgeting or impulsive behavior. These children could also suffer from reduced ability to maintain attention and exhibit difficulty in concentrating on specific tasks. Around one-third of individuals suffering with fragile X syndrome have some symptoms of autism spectrum disorders that disturb communication as well as social interaction. About 15% men and 5% women suffering from fragile X syndrome can experience seizures. These are key factors pushing towards more growth in the global fragile X syndrome market



Market Drivers

Prevalence of fragile X syndrome is rising owing to lack of awareness among people about genetic disorders that result in mutations in DNA. Smoking, consumption of alcohol during pregnancy, and hereditary disorders increase the prevalence of fragile X syndrome

 


1. Global Fragile-X-Syndrome Market Overview....
A. Market Size
2. Global Fragile-X-Syndrome Market Growth Drivers
A. Increase in prevalence of fragile X syndrome
3. Global Fragile-X-Syndrome Market Segmentation
A. By Product type
I. ACT-01
II. AMO-01
III. ANAVEX-273
IV. AUT- 00206
B. By Region
I. North America Market Analysis
II. Europe Market Analysis
III. Asia-Pacific Market Analysis
IV. Latin America Market Analysis
V. Middle East and Africa Market Analysis
C. By End User
I. Hospitals
II. Clinics
III. Research Centres
4. Global Fragile-X-Syndrome Major Market Share
A. Market Analysis, Insights and Forecast
5. Competitive Landscape.....
A. Major Players
B. Products in Pipeline
6. Key Company Profiles
A. Merck & Co. Company overview, Product & Services, Strategies & Financials
B. Eli-lilly Company overview, Product & Services, Strategies & Financials
C. Bellus Health Company overview, Product & Services, Strategies & Financials
7. Healthcare Policies and Regulatory Landscape.
A. Policy Changes and Reimbursement Scenario
8. Factors Driving Market Growth
A. Key Industry Developments
B. Mergers and Acquisitions
9. Market Opportunities and Future Trends
A. Market Opportunities
B. Future Trends
10. Conclusion
CHOOSE LICENCE TYPE
prudent payment methods
Contact Us

Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071

Drop us an email at
sales@prudentmarkets.com

Why Choose Us
24 * 7 Access to Analyst :

Get your pre and post sales queries resolved by our Subject matter experts.

Customization :

We will assist you to customize the report to fit your research needs.

Assured Quality :

Our prime focus is to provide qualitative and accurate data.

Free sample report :

Feel free to order a sample report before purchase.

Security :

Your personal and confidential information is safe and secured.